Medicure (OTCMKTS:MCUJF) Share Price Passes Below 200-Day Moving Average – Should You Sell?

Medicure Inc. (OTCMKTS:MCUJF) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.66 and traded as low as $0.51. Medicure shares last traded at $0.53, with a volume of 3,000 shares traded.

Medicure Trading Down 0.9 %

The business’s 50-day moving average price is $0.57 and its 200 day moving average price is $0.66. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.03 and a quick ratio of 1.64. The firm has a market capitalization of $5.48 million, a price-to-earnings ratio of -3.75 and a beta of 0.98.

Medicure (OTCMKTS:MCUJF) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.05 earnings per share (EPS) for the quarter. Medicure had a negative net margin of 9.62% and a negative return on equity of 10.12%.

Medicure Company Profile

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.